Kim H - Search Results

1

Dynamic contrast enhanced magnetic resonance imaging of an orthotopic pancreatic cancer mouse model.

Kim H, Samuel S, Totenhagen JW, Warren M, Sellers JC, Buchsbaum DJ. Kim H, et al. J Vis Exp. 2015 Apr 18;(98):52641. doi: 10.3791/52641. J Vis Exp. 2015. PMID: 25938718 Free PMC article.

2

Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging.

Kim H, Morgan DE, Buchsbaum DJ, Zeng H, Grizzle WE, Warram JM, Stockard CR, McNally LR, Long JW, Sellers JC, Forero A, Zinn KR. Kim H, et al. Cancer Res. 2008 Oct 15;68(20):8369-76. doi: 10.1158/0008-5472.CAN-08-1771. Cancer Res. 2008. PMID: 18922909 Free PMC article.

3

Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging.

Kim H, Folks KD, Guo L, Sellers JC, Fineberg NS, Stockard CR, Grizzle WE, Buchsbaum DJ, Morgan DE, George JF, Zinn KR. Kim H, et al. Mol Imaging. 2011 Jun;10(3):153-67. Mol Imaging. 2011. PMID: 21496446 Free PMC article.

4

DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy.

Kim H, Folks KD, Guo L, Stockard CR, Fineberg NS, Grizzle WE, George JF, Buchsbaum DJ, Morgan DE, Zinn KR. Kim H, et al. Mol Imaging Biol. 2011 Feb;13(1):94-103. doi: 10.1007/s11307-010-0320-2. Mol Imaging Biol. 2011. PMID: 20383593 Free PMC article.

5

Effect of anti-DR5 and chemotherapy on basal-like breast cancer.

Oliver PG, LoBuglio AF, Zhou T, Forero A, Kim H, Zinn KR, Zhai G, Li Y, Lee CH, Buchsbaum DJ. Oliver PG, et al. Among authors: kim h. Breast Cancer Res Treat. 2012 Jun;133(2):417-26. doi: 10.1007/s10549-011-1755-0. Epub 2011 Sep 7. Breast Cancer Res Treat. 2012. PMID: 21901385 Free PMC article.

6

Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.

Kim H, Zhai G, Samuel SL, Rigell CJ, Umphrey HR, Rana S, Stockard CR, Fineberg NS, Zinn KR. Kim H, et al. Mol Cancer Ther. 2012 Feb;11(2):405-15. doi: 10.1158/1535-7163.MCT-11-0581. Epub 2011 Dec 27. Mol Cancer Ther. 2012. PMID: 22203731 Free PMC article.

7

Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers.

Kim H, Rigell CJ, Zhai G, Lee SK, Samuel SL, Martin A, Umphrey HR, Stockard CR, Beasley TM, Buchsbaum DJ, Li LS, Boothman DA, Zinn KR. Kim H, et al. Mol Imaging Biol. 2014 Feb;16(1):85-94. doi: 10.1007/s11307-013-0665-4. Epub 2013 Jul 9. Mol Imaging Biol. 2014. PMID: 23836505 Free PMC article.

8

Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer.

Kim H, Samuel SL, Zhai G, Rana S, Taylor M, Umphrey HR, Oelschlager DK, Buchsbaum DJ, Zinn KR. Kim H, et al. Cancer Biol Ther. 2014 Aug;15(8):1053-60. doi: 10.4161/cbt.29183. Cancer Biol Ther. 2014. PMID: 25084100 Free PMC article.

9

High-resolution single-photon emission computed tomography and X-ray computed tomography imaging of Tc-99m-labeled anti-DR5 antibody in breast tumor xenografts.

Kim H, Chaudhuri TR, Buchsbaum DJ, Wang D, Zinn KR. Kim H, et al. Mol Cancer Ther. 2007 Mar;6(3):866-75. doi: 10.1158/1535-7163.MCT-06-0230. Mol Cancer Ther. 2007. PMID: 17363481

10

Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.

Oliver PG, LoBuglio AF, Zinn KR, Kim H, Nan L, Zhou T, Wang W, Buchsbaum DJ. Oliver PG, et al. Among authors: kim h. Clin Cancer Res. 2008 Apr 1;14(7):2180-9. doi: 10.1158/1078-0432.CCR-07-1392. Clin Cancer Res. 2008. PMID: 18381960 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97,403 results

Search Page